Cardiac Autonomic Neuropathy and Early Progressive Renal Decline in Patients with Nonmacroalbuminuric Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES: Cardiac autonomic neuropathy predicts future adverse renal outcomes in the general population. This study sought to determine its relationship with early progressive renal decline in type 1 diabetes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A subset of participants with normoalbuminuria (n=204) or microalbuminuria (n=166) from the First Joslin Kidney Study underwent assessment for cardiac autonomic neuropathy using heart rate variability during baseline visits performed from January 1991 to April 1992. Cardiac autonomic neuropathy was defined as an R-R variation (mean circular resultant) <20. Participants also had baseline and follow-up measurement of eGFR. Early progressive renal decline was evaluated according to two definitions: early GFR loss (slope of eGFR estimated by cystatin C <-3.3%/year) and incident advanced CKD (stage ≥3, defined by eGFR [calculated by Modification of Diet in Renal Disease method] <60 ml/min per 1.73 m(2)). Association with baseline cardiac autonomic neuropathy was assessed by adjusted logistic regression and Cox proportional hazards. RESULTS: Among the 370 participants, 47 (13%) had baseline cardiac autonomic neuropathy, 51 (14%) had early GFR loss, and 68 (18%) had incident advanced CKD over a median 14-year follow-up. Early GFR loss occurred in 15 (32%) of the 47 patients with baseline autonomic neuropathy and in 32 (10%) of the 323 without baseline autonomic neuropathy (P<0.001). Baseline autonomic neuropathy was strongly associated with odds of early GFR loss (adjusted odds ratio, 4.09; 95% confidence interval, 1.65 to 10.12; P=0.002). Incident advanced CKD was observed in 22 (47%) of those with baseline autonomic neuropathy and 46 (14%) of those without baseline autonomic neuropathy (P<0.001). Autonomic neuropathy was independently associated with incident advanced CKD (adjusted hazard ratio, 2.76; 95% confidence interval, 1.44 to 5.30; P=0.002). CONCLUSIONS: Cardiac autonomic neuropathy was a strong independent predictor of the long-term risk of early progressive renal decline in type 1 diabetes. Future research should explore the mechanisms by which autonomic neuropathy may be associated with renal function loss.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Timely detection of CAN may help implementation of tailored interventions to prevent its progression and mitigate the risk of associated complications, including CVD, cardiac arrhythmias, myocardial dysfunction leading to congestive heart failure (CHF), CKD, and all-cause mortality.547,614,617–625”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [621]
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
A Controlled Trial of Renal Denervation for Resistant Hypertension
Bhatt, D. L., Kandzari, D. E., O'Neill, W. W., D'Agostino, R., Flack, J. M., Katzen, B. T., Leon, M. B., Liu, M., Mauri, L., Negoita, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402670 · Cited by 2,186
Changes in diabetes-related complications in the United States, 1990-2010
Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749 · cited 3×
“In the nondiabetic population, the Atherosclerosis Risk in Communities study— which followed 13,241 adults, 12% of whom had baseline type 2 diabetes—demonstrated that low HRV was associated with the subsequent development of ESRD and CKDrelated hospitalization after 16 years of follow-up (17).”
BackgroundTemporal trends in the prevalence of diabetic kidney disease in the United States
de Boer, I. H. (2011) · JAMA · doi:10.1001/jama.2011.861 · Cited by 1,036 · cited 1×
“Finally, the overall prevalence of DN continues to increase in proportion to the rising prevalence of diabetes (3,8).”
BackgroundAlbuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes
Ninomiya, T., Perkovic, V., de Galan, B. E., Zoungas, S., Pillai, A., Jardine, M., Patel, A., Cass, A., Neal, B., Poulter, N., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008121270 · Cited by 965
Spallone, V., Ziegler, D., Freeman, R., Bernardi, L., Frontoni, S., Pop‐Busui, R., Stevens, M., Kempler, P., Hilsted, J., Tesfaye, S., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1239 · Cited by 957 · cited 2×
“001 Early GFR loss, n (%) 15 (32) 36 (11) ,0.”
BackgroundSelf-citationRegression of Microalbuminuria in Type 1 Diabetes
Perkins, B. A., Ficociello, L. H., Silva, K. H., Finkelstein, D. M., Warram, J. H., & Krolewski, A. S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021835 · Cited by 801
Self-citationIncrease in Nocturnal Blood Pressure and Progression to Microalbuminuria in Type 1 Diabetes
Lurbe, E., Redon, J., Kesani, A., Pascual, J. M., Tacons, J., Alvarez, V., & Batlle, D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013410 · Cited by 729
(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.193 · Cited by 653
Maser, R. E., Mitchell, B. D., Vinik, A. I., & Freeman, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1895 · Cited by 578
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes
The DCCT/EDIC Research Group (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1111732 · Cited by 568
Pop-Busui, R., Evans, G. W., Gerstein, H. C., Fonseca, V., Fleg, J. L., Hoogwerf, B. J., Genuth, S., Grimm, R. H., Corson, M. A., Prineas, R., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0125 · Cited by 540
Self-citationAAEM minimonograph #26: The electrodiagnosis of carpal tunnel syndrome
Stevens, J. C. (1997) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199712)20:12 · Cited by 518
(1987) · Diabetes Care · doi:10.2337/diacare.10.1.1 · Cited by 479
Krolewski, A. S., Laffel, L. M. B., Krolewski, M., Quinn, M., & Warram, J. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505113321902 · Cited by 452
Self-citationMicroalbuminuria and the Risk for Early Progressive Renal Function Decline in Type 1 Diabetes
Perkins, B. A., Ficociello, L. H., Ostrander, B. E., Silva, K. H., Weinberg, J., Warram, J. H., & Krolewski, A. S. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080872 · Cited by 370
Self-citationCirculating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes
Gohda, T., Niewczas, M. A., Ficociello, L. H., Walker, W. H., Skupien, J., Rosetti, F., Cullere, X., Johnson, A. C., Crabtree, G., Smiles, A. M., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060628 · Cited by 356
Self-citationPhysiology in perspective: The Wisdom of the Body. Neural control of the kidney
DiBona, G. F. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00258.2005 · Cited by 328
Perkins, B. A., Nelson, R. G., Ostrander, B. E. P., Blouch, K. L., Krolewski, A. S., Myers, B. D., & Warram, J. H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100854 · Cited by 323
Self-citationPerkins, B. A., Ficociello, L. H., Roshan, B., Warram, J. H., & Krolewski, A. S. (2010) · Kidney International · doi:10.1038/ki.2009.399 · Cited by 289
Self-citationKrolewski, A. S., Niewczas, M. A., Skupien, J., Gohda, T., Smiles, A., Eckfeldt, J. H., Doria, A., & Warram, J. H. (2014) · Diabetes Care · doi:10.2337/dc13-0985 · Cited by 276
Self-citationRecommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy☆
Spallone, V., Bellavere, F., Scionti, L., Maule, S., Quadri, R., Bax, G., Melga, P., Viviani, G. L., Esposito, K., & Morganti, R. (2011) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.07.005 · Cited by 243
Ziegler, D., Zentai, C. P., Perz, S., Rathmann, W., Haastert, B., Döring, A., Meisinger, C., & for the KORA Study Group (2008) · Diabetes Care · doi:10.2337/dc07-1615 · Cited by 210
Van Hoogenhuyze, D., Weinstein, N., Martin, G. J., Weiss, J. S., Schaad, J. W., Sahyouni, X. N., Fintel, D., Remme, W. J., & Singer, D. H. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90327-h · Cited by 206
Risk for ESRD in Type 1 Diabetes Remains High Despite Renoprotection
Rosolowsky, E. T., Skupien, J., Smiles, A. M., Niewczas, M., Roshan, B., Stanton, R., Eckfeldt, J. H., Warram, J. H., & Krolewski, A. S. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040354 · Cited by 191
Self-citationMethods of investigation for cardiac autonomic dysfunction in human research studies
Bernardi, L., Spallone, V., Stevens, M., Hilsted, J., Frontoni, S., Pop‐Busui, R., Ziegler, D., Kempler, P., Freeman, R., Low, P., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1224 · Cited by 176
Self-citationSympathetic dysfunction in type 1 diabetes
Pop-Busui, R., Kirkwood, I., Schmid, H., Marinescu, V., Schroeder, J., Larkin, D., Yamada, E., Raffel, D. M., & Stevens, M. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.033 · Cited by 170 · cited 1×
“With time, sympathetic denervation progresses from the apex of the ventricles toward the base (35,36).”
BackgroundSelf-citationHeart Rate Variability Predicts ESRD and CKD-Related Hospitalization
Brotman, D. J., Bash, L. D., Qayyum, R., Crews, D., Whitsel, E. A., Astor, B. C., & Coresh, J. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009111112 · Cited by 163
Quantitative measurement of cutaneous perception in diabetic neuropathy
Vinik, A. I., Suwanwalaikorn, S., Stansberry, K. B., Holland, M. T., McNitt, P. M., & Colen, L. E. (1995) · Muscle & Nerve · doi:10.1002/mus.880180603 · Cited by 162
MacIsaac, R. J., Tsalamandris, C., Thomas, M. C., Premaratne, E., Panagiotopoulos, S., Smith, T. J., Poon, A. M. T., Jenkins, M. A., Ratnaike, S., Power, D. A., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0275-7 · Cited by 148
Scott, L. J., Warram, J. H., Hanna, L. S., Laffel, L. M. B., Ryan, L., & Krolewski, A. S. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2842 · Cited by 136
Self-citationRafiq, K., Noma, T., Fujisawa, Y., Ishihara, Y., Arai, Y., Nabi, A. H. M. N., Suzuki, F., Nagai, Y., Nakano, D., Hitomi, H., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.064097 · Cited by 125
What Do We Know and We Do Not Know About Cardiovascular Autonomic Neuropathy in Diabetes
Pop-Busui, R. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9367-6 · Cited by 100
Self-citationAutonomic Neuropathy Predicts Deterioration in Glomerular Filtration Rate in Patients With IDDM
Sundkvist, G., & Lilja, B. (1993) · Diabetes Care · doi:10.2337/diacare.16.5.773 · Cited by 84
Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats
Luippold, G. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg584 · Cited by 77
The Selfish Brain And The Barker Hypothesis
Lumbers, E. R., Yu, Z., & Gibson, K. J. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03554.x · Cited by 71
An Improved Method for Measuring Heart-Rate Variability: Assessment of Cardiac Autonomic Function
Weinberg, C. R., & Pfeifer, M. A. (1984) · Biometrics · doi:10.2307/2530931 · Cited by 71
Autonomic Nerve Testing Predicts the Development of Complications
Maguire, A., Craig, M. E., Craighead, A., Chan, A. K. F., Cusumano, J. M., Hing, S. J., Silink, M., Howard, N. J., & Donaghue, K. C. (2006) · Diabetes Care · doi:10.2337/dc06-0793 · Cited by 69
Fernández‐Cruz, A., Noth, R. H., LASSMAN, M. N., Hollis, J. B., & Mulrow, P. J. (1981) · Hypertension · doi:10.1161/01.hyp.3.1.87 · Cited by 56
Taskiran, M., Rasmussen, V., Rasmussen, B. S., Fritz‐Hansen, T., Larsson, H. B. W., Jensen, G. B., & Hilsted, J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01145.x · Cited by 56
Ebbehøj, E., Poulsen, P. L., Hansen, K. W., Knudsen, S. H., Mølgaard, H., & Mogensen, C. (2002) · Diabetologia · doi:10.1007/s00125-002-0869-7 · Cited by 55
Ficociello, L. H., Perkins, B. A., Silva, K. H., Finkelstein, D. M., Ignatowska-Switalska, H., Gaciong, Z., Cupples, L. A., Aschengrau, A., Warram, J. H., & Krolewski, A. S. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03691106 · Cited by 54
Self-citationTorbj�rnsdotter, T., Jaremko, G., & Berg, U. (2001) · Diabetologia · doi:10.1007/s001250100528 · Cited by 53
Forsén, A., Kangro, M., Sterner, G., Norrgren, K., Thorsson, O., Wollmer, P., & Sundkvist, G. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01255.x · Cited by 51
Yun, J., Ahn, Y., Song, K., Yoo, K., Kim, H.-W., Park, Y., & Ko, S. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.01.031 · Cited by 41
Cystatin C and the Risk of Death
Berghout, A., Wulkan, R. W., & den Hollander, J. G. (2005) · New England Journal of Medicine · doi:10.1056/nejmc051667 · Cited by 18
Poulsen, L. (2002) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2002.044 · Cited by 12
Dab, H., Hachani, R., Sakly, M., Bricca, G., & Kacem, K. (2013) · General Physiology and Biophysics · doi:10.4149/gpb_2013054 · Cited by 8
Intensive Therapy and GFR in Type 1 Diabetes
Fabbian, F., Pala, M., & Manfredini, R. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1200746 · Cited by 8
Research works printed but not linked: 1
- Low, 1997, Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects., Muscle Nerve, 20, 1561, 10.1002/(SICI)1097-4598(199712)20:12<1561::AID-MUS11>3.0.CO;2-3 · doi:10.1002/(sici)1097-4598(199712)20:12<1561::aid-mus11>3.0.co;2-3
Cited by
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602
Self-citationDiabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationSpallone, V. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0259 · Cited by 295
The neurovascular unit and the pathophysiologic basis of diabetic retinopathy
Gardner, T. W., & Davila, J. R. (2017) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-016-3548-y · Cited by 193
Metadata
- Authors
- Orlov, S., Cherney, D. Z. I., Pop-Busui, R., Lovblom, L. E., Ficociello, L. H., Smiles, A. M., Warram, J. H., Krolewski, A. S., & Perkins, B. A.
- Affiliations
- Mount Sinai Hospital (CA)
- University of Toronto (CA)
- Joslin Diabetes Center (US)
- Corresponding author
- Orlov, Steven
- Lovblom, Leif E.
- Perkins, Bruce A.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2015-07
- Volume
- 10
- Issue
- 7
- Pages
- 1136-1144
- ISSN
- 1555-9041 (ISSN-L)
- PMC
- PMC4491301
- OpenAlex
- W2401113515
- Cited by
- 57
- References
- 50
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 8 · 2022: 8 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 6 · 2017: 1 · 2016: 5 · 2015: 1
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Toronto
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-41526, R01DK041526, P30DK020572)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Keywords
- neuropathy, type 1 diabetes, diabetic nephropathy, heart rate variability, microalbuminuria, normoalbuminuria, chronic kidney disease progression, estimated glomerular filtration rate decline, cystatin C, cardiovascular risk stratification
- MeSH terms
- Adolescent, Adult, Autonomic Nervous System, Boston, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Diabetic Neuropathies, Female, Follow-Up Studies, Glomerular Filtration Rate, Heart, Heart Rate, Humans, Kidney, Male, Prospective Studies, Risk Factors, Time Factors, Biomarkers, Incidence, Multivariate Analysis, Logistic Models, Proportional Hazards Models, Odds Ratio, Disease Progression, Cystatin C, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.